
GENOMEBIOLOGY . BIOMEDCENTRAL . COM {
}
Title:
Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients | Genome Biology | Full Text
Description:
Background The androgen receptor (AR) is a pivotal drug target for the treatment of prostate cancer, including its lethal castration-resistant (CRPC) form. All current non-steroidal AR antagonists, such as hydroxyflutamide, bicalutamide, and enzalutamide, target the androgen binding site of the receptor, competing with endogenous androgenic steroids. Several AR mutations in this binding site have been associated with poor prognosis and resistance to conventional prostate cancer drugs. In order to develop an effective CRPC therapy, it is crucial to understand the effects of these mutations on the functionality of the AR and its ability to interact with endogenous steroids and conventional AR inhibitors. Results We previously utilized circulating cell-free DNA (cfDNA) sequencing technology to examine the AR gene for the presence of mutations in CRPC patients. By modifying our sequencing and data analysis approaches, we identify four additional single AR mutations and five mutation combinations associated with CRPC. Importantly, we conduct experimental functionalization of all the AR mutations identified by the current and previous cfDNA sequencing to reveal novel gain-of-function scenarios. Finally, we evaluate the effect of a novel class of AR inhibitors targeting the binding function 3 (BF3) site on the activity of CRPC-associated AR mutants. Conclusions This work demonstrates the feasibility of a prognostic and/or diagnostic platform combining the direct identification of AR mutants from patientsโ serum, and the functional characterization of these mutants in order to provide personalized recommendations regarding the best future therapy.
Website Age:
25 years and 10 months (reg. 1999-08-06).
Matching Content Categories {๐}
- Social Networks
- Science
- Education
Content Management System {๐}
What CMS is genomebiology.biomedcentral.com built with?
Custom-built
No common CMS systems were detected on Genomebiology.biomedcentral.com, and no known web development framework was identified.
Traffic Estimate {๐}
What is the average monthly size of genomebiology.biomedcentral.com audience?
๐ Good Traffic: 50k - 100k visitors per month
Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Genomebiology.biomedcentral.com Make Money? {๐ธ}
Display Ads {๐ฏ}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (3)
yourbow.com, google.com, doceree.comHow Much Does Genomebiology.biomedcentral.com Make? {๐ฐ}
Display Ads {๐ฏ}
$690 per month
Our calculations suggest that Genomebiology.biomedcentral.com earns between $462 and $1,271 monthly online from display advertisements.
Keywords {๐}
cookies, bmc, privacy, mutants, page, data, representation, optional, content, analysis, personal, parties, policy, information, manage, genome, biology, mutations, identified, patients, ballandstick, shown, article, contact, editing, authors, choice, essential, make, site, function, advertising, personalisation, usage, social, media, accepting, consent, processing, including, transfers, european, economic, area, varying, standards, protection, preferences, change, choices,
Topics {โ๏ธ}
circulating cell-free dna authors scientific editing privacy choices/manage cookies bmc androgen receptor mutations 1474-760x contact ar mutants mapped ar mutants encoded european economic area x-ray structure state privacy rights ar-lbd mutants accepting optional cookies manage preferences crpc patients personal data optional cookies data protection essential cookies cookies skip cookies policy privacy policy privacy statement usage analysis social media varying standards functional analysis cartoon representation stick representation blue back general enquiries preference centre springer nature content magenta ball choices mutants privacy lbd ball choice make site function advertising personalisation consent processing parties information
Schema {๐บ๏ธ}
WebPage:
mainEntity:
headline:Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients
description:The androgen receptor (AR) is a pivotal drug target for the treatment of prostate cancer, including its lethal castration-resistant (CRPC) form. All current non-steroidal AR antagonists, such as hydroxyflutamide, bicalutamide, and enzalutamide, target the androgen binding site of the receptor, competing with endogenous androgenic steroids. Several AR mutations in this binding site have been associated with poor prognosis and resistance to conventional prostate cancer drugs. In order to develop an effective CRPC therapy, it is crucial to understand the effects of these mutations on the functionality of the AR and its ability to interact with endogenous steroids and conventional AR inhibitors. We previously utilized circulating cell-free DNA (cfDNA) sequencing technology to examine the AR gene for the presence of mutations in CRPC patients. By modifying our sequencing and data analysis approaches, we identify four additional single AR mutations and five mutation combinations associated with CRPC. Importantly, we conduct experimental functionalization of all the AR mutations identified by the current and previous cfDNA sequencing to reveal novel gain-of-function scenarios. Finally, we evaluate the effect of a novel class of AR inhibitors targeting the binding function 3 (BF3) site on the activity of CRPC-associated AR mutants. This work demonstrates the feasibility of a prognostic and/or diagnostic platform combining the direct identification of AR mutants from patientsโ serum, and the functional characterization of these mutants in order to provide personalized recommendations regarding the best future therapy.
datePublished:2016-01-26T00:00:00Z
dateModified:2016-01-26T00:00:00Z
pageStart:1
pageEnd:15
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13059-015-0864-1
keywords:
Androgen receptor
Castration-resistant prostate cancer
Cell-free circulating DNA
Mutations
Drug resistance
Anti-androgens and steroids
Animal Genetics and Genomics
Human Genetics
Plant Genetics and Genomics
Microbial Genetics and Genomics
Bioinformatics
Evolutionary Biology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-015-0864-1/MediaObjects/13059_2015_864_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-015-0864-1/MediaObjects/13059_2015_864_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-015-0864-1/MediaObjects/13059_2015_864_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-015-0864-1/MediaObjects/13059_2015_864_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-015-0864-1/MediaObjects/13059_2015_864_Fig5_HTML.gif
isPartOf:
name:Genome Biology
issn:
1474-760X
volumeNumber:17
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Nada Lallous
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Stanislav V. Volik
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Laboratory for Advanced Genome Analysis (LAGA)
address:
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Shannon Awrey
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Eric Leblanc
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Ronnie Tse
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Josef Murillo
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Kriti Singh
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Arun A. Azad
affiliation:
name:Department of Medical Oncology, BC Cancer Agency
address:
name:Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Alexander W. Wyatt
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Stephane LeBihan
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Laboratory for Advanced Genome Analysis (LAGA)
address:
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Kim N. Chi
affiliation:
name:Department of Medical Oncology, BC Cancer Agency
address:
name:Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Martin E. Gleave
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Paul S. Rennie
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Colin C. Collins
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Laboratory for Advanced Genome Analysis (LAGA)
address:
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Artem Cherkasov
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients
description:The androgen receptor (AR) is a pivotal drug target for the treatment of prostate cancer, including its lethal castration-resistant (CRPC) form. All current non-steroidal AR antagonists, such as hydroxyflutamide, bicalutamide, and enzalutamide, target the androgen binding site of the receptor, competing with endogenous androgenic steroids. Several AR mutations in this binding site have been associated with poor prognosis and resistance to conventional prostate cancer drugs. In order to develop an effective CRPC therapy, it is crucial to understand the effects of these mutations on the functionality of the AR and its ability to interact with endogenous steroids and conventional AR inhibitors. We previously utilized circulating cell-free DNA (cfDNA) sequencing technology to examine the AR gene for the presence of mutations in CRPC patients. By modifying our sequencing and data analysis approaches, we identify four additional single AR mutations and five mutation combinations associated with CRPC. Importantly, we conduct experimental functionalization of all the AR mutations identified by the current and previous cfDNA sequencing to reveal novel gain-of-function scenarios. Finally, we evaluate the effect of a novel class of AR inhibitors targeting the binding function 3 (BF3) site on the activity of CRPC-associated AR mutants. This work demonstrates the feasibility of a prognostic and/or diagnostic platform combining the direct identification of AR mutants from patientsโ serum, and the functional characterization of these mutants in order to provide personalized recommendations regarding the best future therapy.
datePublished:2016-01-26T00:00:00Z
dateModified:2016-01-26T00:00:00Z
pageStart:1
pageEnd:15
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13059-015-0864-1
keywords:
Androgen receptor
Castration-resistant prostate cancer
Cell-free circulating DNA
Mutations
Drug resistance
Anti-androgens and steroids
Animal Genetics and Genomics
Human Genetics
Plant Genetics and Genomics
Microbial Genetics and Genomics
Bioinformatics
Evolutionary Biology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-015-0864-1/MediaObjects/13059_2015_864_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-015-0864-1/MediaObjects/13059_2015_864_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-015-0864-1/MediaObjects/13059_2015_864_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-015-0864-1/MediaObjects/13059_2015_864_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13059-015-0864-1/MediaObjects/13059_2015_864_Fig5_HTML.gif
isPartOf:
name:Genome Biology
issn:
1474-760X
volumeNumber:17
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Nada Lallous
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Stanislav V. Volik
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Laboratory for Advanced Genome Analysis (LAGA)
address:
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Shannon Awrey
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Eric Leblanc
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Ronnie Tse
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Josef Murillo
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Kriti Singh
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Arun A. Azad
affiliation:
name:Department of Medical Oncology, BC Cancer Agency
address:
name:Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Alexander W. Wyatt
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Stephane LeBihan
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Laboratory for Advanced Genome Analysis (LAGA)
address:
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Kim N. Chi
affiliation:
name:Department of Medical Oncology, BC Cancer Agency
address:
name:Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Martin E. Gleave
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Paul S. Rennie
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Colin C. Collins
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Laboratory for Advanced Genome Analysis (LAGA)
address:
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
type:PostalAddress
type:Organization
type:Person
name:Artem Cherkasov
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Genome Biology
issn:
1474-760X
volumeNumber:17
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
name:Laboratory for Advanced Genome Analysis (LAGA)
address:
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
type:PostalAddress
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
name:Department of Medical Oncology, BC Cancer Agency
address:
name:Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada
type:PostalAddress
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
name:Laboratory for Advanced Genome Analysis (LAGA)
address:
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
type:PostalAddress
name:Department of Medical Oncology, BC Cancer Agency
address:
name:Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada
type:PostalAddress
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
name:Laboratory for Advanced Genome Analysis (LAGA)
address:
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
type:PostalAddress
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Nada Lallous
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Stanislav V. Volik
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Laboratory for Advanced Genome Analysis (LAGA)
address:
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
type:PostalAddress
type:Organization
name:Shannon Awrey
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Eric Leblanc
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Ronnie Tse
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Josef Murillo
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Kriti Singh
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Arun A. Azad
affiliation:
name:Department of Medical Oncology, BC Cancer Agency
address:
name:Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada
type:PostalAddress
type:Organization
name:Alexander W. Wyatt
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Stephane LeBihan
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Laboratory for Advanced Genome Analysis (LAGA)
address:
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
type:PostalAddress
type:Organization
name:Kim N. Chi
affiliation:
name:Department of Medical Oncology, BC Cancer Agency
address:
name:Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada
type:PostalAddress
type:Organization
name:Martin E. Gleave
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Paul S. Rennie
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Colin C. Collins
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
name:Laboratory for Advanced Genome Analysis (LAGA)
address:
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
type:PostalAddress
type:Organization
name:Artem Cherkasov
affiliation:
name:University of British Columbia
address:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
name:Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
name:Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
name:Laboratory for Advanced Genome Analysis (LAGA), Vancouver, Canada
name:Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada
External Links {๐}(21)
- What is the earnings of https://www.biomedcentral.com/privacy-statement?
- Profit of https://www.biomedcentral.com
- How much revenue does https://www.biomedcentral.com/journals generate?
- What is the monthly revenue of https://www.biomedcentral.com/getpublished?
- Earnings of https://www.biomedcentral.com/about
- Revenue of https://www.biomedcentral.com/account
- See how much https://submission.springernature.com/new-submission/13059/3 makes per month
- Earnings of https://blogs.biomedcentral.com/
- How much income does https://www.biomedcentral.com/login have?
- See how much https://authorservices.springernature.com/go/sn/?utm_source=Website&utm_medium=BMC&utm_campaign=SNAS+Referrals+2022&utm_id=ref2022 makes per month
- https://www.biomedcentral.com/about/policies income
- How much does https://www.biomedcentral.com/accessibility gross monthly?
- How much cash flow does https://www.biomedcentral.com/about/press-centre have monthly?
- How much revenue does https://support.biomedcentral.com/support/home generate?
- Financial intake of https://biomedcentral.typeform.com/to/VLXboo
- Get to know what's the income of https://www.biomedcentral.com/about/jobs
- What's the income generated by http://www.weibo.com/biomedcentral each month?
- How much revenue does https://www.biomedcentral.com/terms-and-conditions bring in?
- What's https://www.springernature.com/ccpa's gross income?
- What is the monthly revenue of https://www.biomedcentral.com/cookies?
- How much revenue does https://www.springernature.com produce monthly?
Analytics and Tracking {๐}
- Google Tag Manager
Libraries {๐}
- Prism.js